Akcea Therapeutics, Inc. Stock-Based Compensation
Akcea Therapeutics, Inc. reported Stock-Based Compensation of $23.40 million for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2020-08-05
- Akcea Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2020-06-30 was $16.12M, a 12.23% increase year-over-year.
- Akcea Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2020-03-31 was $7.28M, a 60.77% decline year-over-year.
- Akcea Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2019-12-31 was $7.65M, a 41.32% decline year-over-year.
- Akcea Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2019-09-30 was -$3.46M, a 127.21% decline year-over-year.
- Akcea Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2019 was $37.11M, a 16.19% decline from fiscal 2018.
- Akcea Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2018 was $44.28M, a 152.48% increase from fiscal 2017.
- Akcea Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2017 was $17.54M, a 72.82% increase from fiscal 2016.
- Akcea Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2016 was $10.15M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2020-06-30 | $16.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $23.40M 10-Q · filed 2020-08-05 | $31.05M derived: sum of 3 quarters · filed 2020-08-05 | $27.59M derived: sum of 4 quarters · filed 2020-08-05 |
| 2020-03-31 | $7.28M 10-Q · filed 2020-05-06 | $14.94M derived: sum of 2 quarters · filed 2020-05-06 | $11.47M derived: sum of 3 quarters · filed 2020-05-06 | $25.83M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-12-31 | $7.65M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $4.19M derived: sum of 2 quarters · filed 2020-03-02 | $18.55M derived: sum of 3 quarters · filed 2020-08-05 | $37.11M 10-K · filed 2020-03-02 |
| 2019-09-30 | -$3.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $10.90M derived: sum of 2 quarters · filed 2020-08-05 | $29.46M 10-Q · filed 2019-11-06 | $42.50M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-06-30 | $14.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $32.92M 10-Q · filed 2020-08-05 | $45.97M derived: sum of 3 quarters · filed 2020-08-05 | $58.70M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | $18.56M 10-Q · filed 2020-05-06 | $31.60M derived: sum of 2 quarters · filed 2020-05-06 | $44.33M derived: sum of 3 quarters · filed 2020-05-06 | $56.46M derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | $13.04M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $25.77M derived: sum of 2 quarters · filed 2020-03-02 | $37.90M derived: sum of 3 quarters · filed 2020-03-02 | $44.28M 10-K · filed 2020-03-02 |
| 2018-09-30 | $12.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $24.86M derived: sum of 2 quarters · filed 2019-11-06 | $31.24M 10-Q · filed 2019-11-06 | $36.96M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $12.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $18.51M 10-Q · filed 2019-08-07 | $24.23M derived: sum of 3 quarters · filed 2020-03-02 | $28.93M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $6.38M 10-Q · filed 2019-05-09 | $12.11M derived: sum of 2 quarters · filed 2020-03-02 | $16.80M derived: sum of 3 quarters · filed 2020-03-02 | $20.74M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $5.72M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $10.42M derived: sum of 2 quarters · filed 2020-03-02 | $14.36M derived: sum of 3 quarters · filed 2020-03-02 | $17.54M 10-K · filed 2020-03-02 |
| 2017-09-30 | $4.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $8.63M derived: sum of 2 quarters · filed 2018-11-06 | $11.81M 10-Q · filed 2018-11-06 | $14.28M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $3.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $7.12M 10-Q · filed 2018-08-07 | $9.59M derived: sum of 3 quarters · filed 2019-03-01 | $12.10M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $3.18M 10-Q · filed 2018-05-07 | $5.65M derived: sum of 2 quarters · filed 2019-03-01 | $8.16M derived: sum of 3 quarters · filed 2019-03-01 | |
| 2016-12-31 | $2.47M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $4.98M derived: sum of 2 quarters · filed 2019-03-01 | $10.15M 10-K · filed 2019-03-01 | |
| 2016-09-30 | $2.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $7.68M 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | $5.17M 10-Q · filed 2017-08-09 | |||
| 2015-12-31 | $6.50M 8-K · filed 2018-09-18 |